Our goal with using this approach in both HFD-only and HFD + STZ cohorts was to investigate obesity-driven dysfunction from STZ-mediated β-cell injury and to resolve insulin resistance-specific circulating signatures and pathway shifts that have significant translational relevance. The gene discussed is INS; the disease is obesity disorder.